NewsWhore
08-13-2009, 07:20 PM
/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP), today announced that it has received approval to begin marketing the Quill(TM) SRS Polydioxanone (PDO), MONODERM(TM),...
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/26985368/)
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/26985368/)